These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 16236116)
1. Prophylactic treatment with FEIBA of a haemophilia A patient with inhibitor: what are the costs, what are the benefits? Siegmund B; Richter H; Pollmann H Haemophilia; 2005 Nov; 11(6):638-41. PubMed ID: 16236116 [No Abstract] [Full Text] [Related]
2. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding. Economou M; Teli A; Tzantzaroudi A; Tsatra I; Zavitsanakis A; Athanassiou-Metaxa M Haemophilia; 2008 Mar; 14(2):390-1. PubMed ID: 18194305 [No Abstract] [Full Text] [Related]
3. Cost minimization analysis to compare activated prothrombin complex concentrate (APCC) and recombinant factor VIIa for haemophilia patients with inhibitors undergoing major orthopaedic surgeries. Bonnet PO; Yoon BS; Wong WY; Boswell K; Ewenstein BM Haemophilia; 2009 Sep; 15(5):1083-9. PubMed ID: 19456876 [TBL] [Abstract][Full Text] [Related]
4. In vivo haemostatic effects of activated prothrombin complex concentrate and recombinant factor VIIa in a haemophilia A patient with inhibitors. Grossmann R; Geisen U; Walter U Haemophilia; 2001 Nov; 7(6):589-91. PubMed ID: 11851758 [No Abstract] [Full Text] [Related]
5. Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors. Martinowitz U; Livnat T; Zivelin A; Kenet G Haemophilia; 2009 Jul; 15(4):904-10. PubMed ID: 19473416 [TBL] [Abstract][Full Text] [Related]
6. Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review. Mathew P; Young G Haemophilia; 2006 Sep; 12(5):457-72. PubMed ID: 16919075 [TBL] [Abstract][Full Text] [Related]
7. A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors. Putnam KG; Bohn RL; Ewenstein BM; Winkelmayer WC; Avorn J Haemophilia; 2005 May; 11(3):261-9. PubMed ID: 15876272 [TBL] [Abstract][Full Text] [Related]
8. From theory to practice: applying current clinical knowledge and treatment strategies to the care of hemophilia a patients with inhibitors. Gomperts ED; Astermark J; Gringeri A; Teitel J Blood Rev; 2008 Feb; 22 Suppl 1():S1-11. PubMed ID: 18485996 [TBL] [Abstract][Full Text] [Related]
10. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry. Parameswaran R; Shapiro AD; Gill JC; Kessler CM; Haemophilia; 2005 Mar; 11(2):100-6. PubMed ID: 15810910 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer. Franchini M; Capra F; Capelli C; de Maria E; Lippi G; Gandini G Haematologica; 2001 Apr; 86(4):E12. PubMed ID: 11325664 [No Abstract] [Full Text] [Related]
13. FEIBA in the treatment of acquired haemophilia A: results from the prospective multicentre French 'FEIBA dans l'hémophilie A acquise' (FEIBHAC) registry. Borg JY; Négrier C; Durieu I; Dolimier E; Masquelier AM; Lévesque H; Haemophilia; 2015 May; 21(3):330-337. PubMed ID: 25359571 [TBL] [Abstract][Full Text] [Related]
14. Cost minimization model for treatment of minor bleeding episodes in inhibitor patients -- methodological issues. Seremetis S; Joshi AV; Asmussen M Haemophilia; 2006 Jan; 12(1):108-9. PubMed ID: 16409187 [No Abstract] [Full Text] [Related]
15. Possible synergy between recombinant factor VIIa and prothrombin complex concentrate in hemophilia therapy. Key NS; Christie B; Henderson N; Nelsestuen GL Thromb Haemost; 2002 Jul; 88(1):60-5. PubMed ID: 12152680 [TBL] [Abstract][Full Text] [Related]
16. Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody. Monahan PE; Aledort LM; Am J Hematol; 2004 Dec; 77(4):346-50. PubMed ID: 15558804 [TBL] [Abstract][Full Text] [Related]
17. Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors. Valentino LA Haemophilia; 2010 Mar; 16(2):263-71. PubMed ID: 20028421 [TBL] [Abstract][Full Text] [Related]
18. Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma and administration of recombinant factor VIII and activated factor VII. Koyama T; Nagao T; Tsunozaki H; Arai M; Miura O Pathophysiol Haemost Thromb; 2006; 35(5):405-7. PubMed ID: 17230044 [No Abstract] [Full Text] [Related]
19. Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review. Kraut EH; Aledort LM; Arkin S; Stine KC; Wong WY Haemophilia; 2007 Sep; 13(5):508-17. PubMed ID: 17880437 [TBL] [Abstract][Full Text] [Related]
20. A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors. Chuansumrit A; Sri-Udomporn N; Srimuninnimit V; Juntarukha R Haemophilia; 2001 Sep; 7(5):532-4. PubMed ID: 11554948 [No Abstract] [Full Text] [Related] [Next] [New Search]